CRDG UK

Propelling research and development of pharmaceutical cannabinoid related products in the UK Media 07870515025

[CRDG UK @crdguk]

UK life sciences can lead the way in cannabinoid R&D - our co-chair Professor Trevor Jones rallying call in this month’s ⁦@DDWJournal⁩ https://t.co/jorbzMNgDz

[Artelo Biosciences Inc. @ArteloBio]

FABP5 was recently featured as a potential new therapeutic target for #pain in the European Journal of Pain @EFICPain

This paper shifts the paradigm:
- Pain is not just neuronal—it’s lipid signaling dysregulation
- FABP5 sits upstream of multiple pain pathways
- Modulating FABP5 enables system-wide effects

Unlike opioids (single receptor), this approach:
- Rebalances endogenous signaling
- Expands therapeutic reach
- May reduce tolerance risk

ART26.12 is $ARTL's #FABP5 inhibitor being developed to treat the network—not just the signal—in neuropathic pain.

Read the publication here: https://t.co/XgVGLr1lG3

[CRDG UK @crdguk]

Our response to the new ACMD advice. Calling on ⁦@DianaJohnsonMP⁩ to act https://t.co/vDsOYIlZbk

[CRDG UK @crdguk]

Outstanding inspection results from our founding member

[Curaleaf International @curaleafint]

Leading the way in UK medical cannabis care @CuraleafClinic. Following its latest inspection, our clinic has retained its Outstanding rating in the 'Well-led' category and ‘Good’ overall from the @CareQualityComm, reaffirming its position as the highest-rated medical cannabis clinic in the UK.

With growing patient demand, the clinic remains committed to delivering high-quality, evidence-based care, setting the benchmark for the industry.

This achievement reflects our team's dedication and commitment to advancing medical cannabis access and research.

🔗 Read more: https://t.co/1Q6iKyF65x

#MedicalCannabis #HealthcareInnovation #OneCuraleaf

[CRDG UK @crdguk]

Important new data just published

[Curaleaf Clinic @CuraleafClinic]

Curaleaf Clinic is proud to share findings from our latest study on the impact of medical cannabis on sleep and chronic pain.

Ready to learn more? Read the full blog now to dive into the findings and their impact.
https://t.co/ZomLznBA9Z

[CRDG UK @crdguk]

This is very good

[Will Lawn @Will_Lawn]

Sharing a new animation from the science channel @Kurz_Gesagt about the potential risks of heavy, long-term #cannabis use. I helped with scientific content and fact-checking. Kurzgesagt has >23 mil subscribers on Youtube - it's a privilege to be involved https://t.co/xPBzwXyYsW

[CRDG UK @crdguk]

Fabulous Group meeting yesterday hosted by https:/thepioneergroup.com/ at their landmark new centre in Bloomsbury Square. Great to be joined by @charliecraddock who delivered a bravura presentation on https://t.co/piwugtBrNV

[George Freeman FRSA MP @MPGeorgeFreeman]

My question at #PMQs today:
To build the industries of tomorrow HERE we need to unlock the hundreds of billions in UK pension funds in the City.
Will the new Govt commit to the last Govt's reforms to the pension industry to unlock capital for British R+D growth?
@BIA_UK

[CRDG UK @crdguk]

@SamueJArmstrong And https://t.co/ServMXi9AE down …

[CRDG UK @crdguk]

Today at PMQ’s our Co-Chair George Freeman MP posed this important question to the Prime Minister https://t.co/yHcBWIQk1j

[George Freeman FRSA MP @MPGeorgeFreeman]

Delighted to have been elected onto the Science, Technology+Innovation Select Committee @CommonsSITC

(Reflecting the representation of MPs after GE24 nearly all the Committees are Labour chaired now & I look forwd to working with my former Shadow, friend & Chair @ChiOnwurah🤝)

[CRDG UK @crdguk]

We host our first investor round table in London this morning. Excited to see interest of so many in cannabinoid R&D potential

[CRDG UK @crdguk]

A fine report of our most recent event highlighting the deleterious consequences of Home Office delaying medical cannabis research licences https://t.co/pSFXcRBJe7

[George Freeman FRSA MP @MPGeorgeFreeman]

As Chair of All Party Parliamentary & Scientific Committee, & former Minister for Science, Research & Innovation I have written to @RachelReevesMP to stress importance of R&D in growing the economy & tackling the big challenges we face...
@sciencecampaign
https://t.co/vPtoJRdwWI

[CRDG UK @crdguk]

Learn more about how you can join our Group https://t.co/samDpxwOew

[Anastasia Bektimirova @anastasiabekt]

A good glimpse into Patrick Vallance’s ambitions for UKRI here, and the model he expects the next UKRI CEO to aim for:

“UKRI shouldn’t be a research council on top of the research councils. It should be a strategic organisation that is able to accommodate within it a diversity of research funding approaches.

I’m concerned that a number of new and more innovative funding approaches got set up outside UKRI because it was deemed, probably correctly, that UKRI, as it was set up, didn’t have the ability to manage that diversity appropriately.

UKRI is not a monolithic corporate organisation. It’s something that ought to be able to have underneath it a mix of things, and it ought to see the overall landscape and be able to understand where and how it can facilitate that. That’s the model I think we need to work for.”

[George Freeman FRSA MP @MPGeorgeFreeman]

Honoured to have been (s)elected by fellow @Conservatives MPs as one of our 2️⃣ nominations for the Commons Science, Technology & Innovation Select Committee @CommonsSITC chaired by my friend and former Shadow Minister @ChiOnwurah

@ParlSciCom @PARLYapp @UKParliament @LordsSTCom

[Allan Nixon @AllanNixon]

Tomorrow we’re publishing a report - jointly with @InstituteGC - on the bold reforms needed to the UK’s capital markets to unlock science & tech growth 👇

[CRDG UK @crdguk]

Tomorrow we are hosting a webinar focusing on our latest report which addresses the delays caused by Home Office licensing delays

Register here 👇

https://t.co/aWhcpFeieN

[CRDG UK @crdguk]

Our new report picked up in @thetimes

[Andrew Ellson @andrewellson]

Home Office dept licensing cannabis research is "not fit for purpose"
-it only accept emails and voicemail and there's no way to speak to a human
-it takes a month on average to reply to an email
-Vital research into new medicines being delayed
My story:
https://t.co/1HNxIgFJ76

[CRDG UK @crdguk]

Update on our new report published today and coverage in @thetimes
https://t.co/jB3kGdDRpD